Table 1a.
Schizophrenia |
Controls |
|||||
---|---|---|---|---|---|---|
Characteristic | N | Mean Across Samples | SD Across Samples | N | Mean Across Samples | SD Across Samples |
Group Size | 219 | 34.94 | 27.23 | 219 | 36.68 | 31.60 |
Age | 204 (201) |
30.74 (7.20) |
8.27 (2.97) |
204 (201) |
30.39 (7.15) |
8.53 (3.28) |
Sex | 216 | 66.74 | 28.60 | 216 | 64.17 | 28.96 |
Handedness | 138 | 92.76 | 9.42 | 137 | 94.35 | 7.55 |
Ethnicity | 32 | 70.94 | 26.07 | 32 | 76.03 | 21.84 |
Education | 90 (89) |
12.42 (2.48) |
1.72 (0.84) |
90 (89) |
14.01 (2.50) |
1.90 (1.12) |
Socioeconomic Status | 48 (48) |
2.88 (1.02) |
0.57 (0.39) |
47 (47) |
2.62 (0.92) |
0.60 (0.31) |
Intelligence Quotient | 45 (44) |
97.61 (13.68) |
9.45 (3.51) |
45 (44) |
109.79 (11.70) |
7.34 (2.84) |
Height | 37 (37) |
170.11 (8.11) |
6.82 (2.16) |
37 (37) |
171.59 (7.69) |
7.09 (2.20) |
Scanning Parameters | ||||||
Magnetic Field Strength | ||||||
0.5 T | 1 | 0.5% | ||||
1.0 T | 5 | 2.3% | ||||
1.5 T | 180 | 82.2% | ||||
2.0 T | 1 | 0.5% | ||||
3.0 T | 20 | 9.1% | ||||
Slice Thickness | 181 | 1.59 | 0.83 | |||
Slice Gap Width | 124 | 0.07 | 0.35 | |||
Intrarater Reliability | 71 | 0.91 | 0.08 | |||
Interrater Reliability | 31 | 0.92 | 0.07 | |||
Clinical Characteristics | ||||||
First-Episode (%) | 63 | 94.53 | 18.10 | |||
Chronic (%) | 27 | 97.91 | 10.88 | |||
Inpatient (%) | 10 | 71.94 | 32.77 | |||
Outpatient (%) | 14 | 78.97 | 33.52 | |||
Medicated (%) | 82 | 90.66 | 24.16 | |||
Antipsychotic Dosage | 68 (66) |
468.17 (344.97) |
220.16 (174.51) |
|||
Illness Onset | 94 (94) |
22.64 (5.47) |
3.79 (1.70) |
|||
Illness Duration | 131 (129) |
9.65 (6.10) |
7.11 (3.56) |
|||
Symptom Severity | 51 (51) |
71.52 (16.53) |
15.02 (5.25) |
Note. Group proportions or means within samples are shown with standard deviations enclosed in parentheses where appropriate. N (number of samples reporting a given characteristic), sex (proportion male), handedness (proportion right-handed), ethnicity (proportion European ancestry), education (years of formal education), height (centimeters), socioeconomic status (parental socioeconomic status rated on the Hollingshead Index), antipsychotic dosage (daily dosage in chlorpromazine equivalents only for antipsychotic exposed samples), illness onset (age at schizophrenia onset), symptom severity (Positive and Negative Symptom Scale overall score).